Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 12/2011

01-11-2011 | Translational Research

Enhancing Surgical Vision by Using Real-Time Imaging of αvβ3-Integrin Targeted Near-Infrared Fluorescent Agent

Authors: George Themelis, PhD, Niels J. Harlaar, MD, Wendy Kelder, MD, Joost Bart, MD, Athanasios Sarantopoulos, MSc, Gooitzen M. van Dam, MD, Vasilis Ntziachristos, MSc, PhD

Published in: Annals of Surgical Oncology | Issue 12/2011

Login to get access

Abstract

Background

This study was designed to improve the surgical procedure and outcome of cancer surgery by means of real-time molecular imaging feedback of tumor spread and margin delineation using targeted near-infrared fluorescent probes with specificity to tumor biomarkers. Surgical excision of cancer often is confronted with difficulties in the identification of cancer spread and the accurate delineation of tumor margins. Currently, the assessment of tumor borders is afforded by postoperative pathology or, less reliably, intraoperative frozen sectioning. Fluorescence imaging is a natural modality for intraoperative use by directly relating to the surgeon’s vision and offers highly attractive characteristics, such as high-resolution, sensitivity, and portability. Via the use of targeted probes it also becomes highly tumor-specific and can lead to significant improvements in surgical procedures and outcome.

Methods

Mice bearing xenograft human tumors were injected with αvβ3-integrin receptor-targeted fluorescent probe and in vivo visualized by using a novel, real-time, multispectral fluorescence imaging system. Confirmatory ex vivo imaging, bioluminescence imaging, and histopathology were used to validate the in vivo findings.

Results

Fluorescence images were all in good correspondence with the confirming bioluminescence images in respect to signal colocalization. Fluorescence imaging detected all tumors and successfully guided total tumor excision by effectively detecting small tumor residuals, which occasionally were missed by the surgeon. Tumor tissue exhibited target-to-background ratio of ~4.0, which was significantly higher compared with white-light images representing the visual contrast. Histopathology confirmed the capability of the method to identify tumor negative margins with high specificity and better prediction rate compared with visual inspection.

Conclusions

Real-time multispectral fluorescence imaging using tumor specific molecular probes is a promising modality for tumor excision by offering real time feedback to the surgeon in the operating room.
Appendix
Available only for authorised users
Literature
1.
Fang W, Chen W, Chen G, et al. Surgical management of thymic epithelial tumors: a retrospective review of 204 cases. Ann Thorac Surg. 2005;80(6):2002–7.PubMedCrossRef
2.
Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer. 2005;104(4):669–75.PubMedCrossRef
3.
Pitz CC, de la Riviere AB, van Swieten HA, et al. Surgical treatment of Pancoast tumours. Eur J Cardiothorac Surg. 2004;26(1):202–8.PubMedCrossRef
4.
Pendlebury SC, Ivanov O, Renwick S, et al. Long-term review of a breast conservation series and patterns of care over 18 years. ANZ J Surg. 2003;73(8):577–83.PubMedCrossRef
5.
Kestin LL, Goldstein NS, Lacerna MD, et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer. 2000;88(3):596–607.PubMedCrossRef
6.
Lacquet LK. The present status of surgery for lung cancer. Acta Chir Belg. 1996;96(6):245–51.PubMed
7.
Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 1996;78(9):1921–8.PubMedCrossRef
8.
Pleijhuis RG, Graafland M, de Vries J, et al. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol. 2009;16:2717–2730.PubMedCrossRef
9.
de Gara CJ, Hanson J, Hamilton S. A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival. Am J Surg. 2003;186(1):23–7.PubMedCrossRef
10.
Cao D, Lin C, Woo SH, et al. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. Am J Surg Pathol. 2005;29(12):1625–32.PubMedCrossRef
11.
DiMusto PD, Orringer MB. Transhiatal esophagectomy for distal and cardia cancers: implications of a positive gastric margin. Ann Thorac Surg. 2007;83(6):1993–8 (discussion 1998–9)PubMedCrossRef
12.
Wray CJ, Ahmad SA, Matthews JB, et al. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128(6):1626–41.PubMedCrossRef
13.
Braat AE, Oosterhuis JW, de Vries JE, et al. Lymphatic staging in colorectal cancer: pathologic, molecular, and sentinel node techniques. Dis Colon Rectum. 2005;48(2):371–83.PubMedCrossRef
14.
Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg. 2003;186(2):112–6.PubMedCrossRef
15.
Juretzka MM, Chi DS, Sonoda Y. Update on surgical treatment for endometrial cancer. Expert Rev Anticancer Therapy. 2005;5(1):113–21.CrossRef
16.
Smeets A, Christiaens MR. Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment. Curr Opin Oncol. 2005;17(6):539–44.PubMedCrossRef
17.
Roukos DH, Kappas AM. Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol. 2005;2(2):98–107.PubMedCrossRef
18.
Tsukamoto T, Kitamura H, Takahashi A, et al. Treatment of invasive bladder cancer: lessons from the past and perspective for the future. Jpn J Clin Oncol. 2004;34(6):295–306.PubMedCrossRef
19.
Kabuto M, Kubota T, Kobayashi H, et al. Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. Neurol Res. 1997;19(1):9–16.PubMed
20.
Moore GE. Fluorescein as an agent in the differentiation of normal and malignant tissues. Science. 1947;106(2745):130–1.PubMedCrossRef
21.
Stummer W, Reulen HJ, Novotny A, et al. Fluorescence-guided resections of malignant gliomas—an overview. Acta Neurochir Suppl. 2003;88:9–12.PubMed
22.
Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998;42(3):518–25; discussion 525–6PubMedCrossRef
23.
Haglund MM, Berger MS, Hochman DW. Enhanced optical imaging of human gliomas and tumor margins. Neurosurgery. 1996;38(2):308–17.PubMedCrossRef
24.
Kremer P, Wunder A, Sinn H, et al. Laser-induced fluorescence detection of malignant gliomas using fluorescein-labeled serum albumin: experimental and preliminary clinical results. Neurol Res. 2000;22(5):481–9.PubMed
25.
Kircher MF, Mahmood U, King RS, et al. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 2003;63(23):8122–5.PubMed
26.
Adusumilli PS, Stiles BM, Chan MK, et al. Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery. FASEB J. 2006;20(6):726–8.PubMed
27.
Stummer W, Novotny A, Stepp H, et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93(6):1003–13.PubMedCrossRef
28.
Eisenberg DP, Adusumilli PS, Hendershott KJ, et al. Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus. Ann Surg. 2006;243(6):824–30 (discussion 830–2).PubMedCrossRef
29.
Tanaka E, Choi HS, Fujii H, et al. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol. 2006;13(12):1671–81.PubMedCrossRef
30.
Sato K, Nariai T, Sasaki S, et al. Intraoperative intrinsic optical imaging of neuronal activity from subdivisions of the human primary somatosensory cortex. Cereb Cortex. 2002;12(3):269–80.PubMedCrossRef
31.
Haglund MM, Hochman DW. Imaging of intrinsic optical signals in primate cortex during epileptiform activity. Epilepsia. 2007;48(Suppl 4):65–74.PubMedCrossRef
32.
Nakayama A, del Monte F, Hajjar RJ, et al. Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol Imaging. 2002;1(4):365–77.PubMedCrossRef
33.
Bogaards A, Varma A, Collens SP, et al. Increased brain tumor resection using fluorescence image guidance in a preclinical model. Lasers Surg Med. 2004;35(3):181–90.PubMedCrossRef
34.
Ray ER, Chatterton K, Khan MS, et al. Hexylaminolaevulinate ‘blue light’ fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. BJU Int. 2009;103(10):1363–7.PubMedCrossRef
35.
Bogaards A, Varma A, Collens SP, et al. Increased brain tumor resection using fluorescence image guidance in a preclinical model. Lasers Surg Med. 2004; 35(3):181–90.PubMedCrossRef
36.
Stummer W, Novotny A, Stepp H, et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93(6):1003–13.PubMedCrossRef
37.
Ntziachristos V, Ripoll J, Wang LV, et al. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 2005;23(3):313–20.PubMedCrossRef
38.
Yang VX, Muller PJ, Herman P, et al. A multispectral fluorescence imaging system: design and initial clinical tests in intra-operative Photofrin-photodynamic therapy of brain tumors. Lasers Surg Med. 2003;32(3):224–32.PubMedCrossRef
39.
Ntziachristos V, Turner G, Dunham J, et al. Planar fluorescence imaging using normalized data. J Biomed Opt. 2005;10(6):064007.PubMedCrossRef
40.
Bogaards A, Sterenborg HJ, Trachtenberg J, et al. In vivo quantification of fluorescent molecular markers in real-time by ratio imaging for diagnostic screening and image-guided surgery. Lasers Surg Med. 2007;39(7):605–13.PubMedCrossRef
41.
Themelis G, Yoo JS, Ntziachristos V. Multispectral imaging using multiple-bandpass filters. Opt Lett. 2008;33(9):1023–5.PubMedCrossRef
42.
Themelis G, Yoo JS, Soh KS, et al. Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt. 2009;14(6):064012.PubMedCrossRef
43.
Vellon L, Menendez JA, Lupu R. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene. 2005;24(23):3759–73.PubMedCrossRef
44.
Rabb H, Barroso-Vicens E, Adams R, et al. Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney. Am J Nephrol. 1996;16(5):402–8.PubMedCrossRef
45.
Pecheur I, Peyruchaud O, Serre CM, et al. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J. 2002;16(10):1266–8.PubMed
46.
Gasparini G, Brooks PC, Biganzoli E, et al. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res. 1998;4(11):2625–34.PubMed
47.
Kossodo S, Pickarski M, Lin SA, et al. Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT). Mol Imaging Biol. 12(5):488–99.
48.
Weissleder R, Tung CH, Mahmood U, et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999;17(4):375–8.PubMedCrossRef
49.
Razansky D. Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo. Nat Photon. 2009;3:412–417.
Metadata
Title
Enhancing Surgical Vision by Using Real-Time Imaging of αvβ3-Integrin Targeted Near-Infrared Fluorescent Agent
Authors
George Themelis, PhD
Niels J. Harlaar, MD
Wendy Kelder, MD
Joost Bart, MD
Athanasios Sarantopoulos, MSc
Gooitzen M. van Dam, MD
Vasilis Ntziachristos, MSc, PhD
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 12/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1664-9

Other articles of this Issue 12/2011

Annals of Surgical Oncology 12/2011 Go to the issue

Palliative Care

When a Chance to Cut Is Not a Chance to Cure: A Future for Palliative Surgery?

Gynecologic Oncology

Prognostic Significance of Stromal Microinvasion in the Intestinal Type of Ovarian Mucinous Adenocarcinoma

Breast Oncology

Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer

Gastrointestinal Oncology

Survival Factors in Patients with Recurrence After Curative Resection of Esophageal Squamous Cell Carcinomas

Melanomas

What is the Significance of the In Transit or Interval Sentinel Node in Melanoma?

Radiation Oncology

Avoiding Mastectomy: Accelerated Partial Breast Irradiation for Breast Cancer Patients with Pacemakers or Defibrillators